| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/13/2000 | WO1999053897A3 Topical formulation comprising poloxamers and further microbicides, and an applicator |
| 04/13/2000 | CA2346687A1 Use of rar antagonists or inverse agonists as male anit-fertility agents |
| 04/13/2000 | CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | CA2346443A1 Prostaglandin receptor ligands |
| 04/13/2000 | CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | CA2345817A1 Novel methods for therapeutic vaccination |
| 04/13/2000 | CA2345808A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2341346A1 Non-peptide gnrh agents, methods and intermediates for their preparation |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists |
| 04/12/2000 | EP0991419A1 Treatment of infertility with leptin receptor ligands |
| 04/12/2000 | CN1250373A Composition and method for suppelmenting testosterone in women with symptoms of testosterone deficiency |
| 04/12/2000 | CN1249932A New application of Modafenyl and its optical antimer1 and isomer-d |
| 04/12/2000 | CN1051230C Medicine for preventing and curing pregnancy of monster |
| 04/11/2000 | US6048970 Prostate growth-associated membrane proteins |
| 04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
| 04/11/2000 | US6048888 Method and pharmaceutical formulation for treating benign prostatic hyperplasia |
| 04/11/2000 | US6048864 Benign prostatic hyperplasia |
| 04/11/2000 | US6048534 Methods and compositions for the selective regulation of chorionic prostanoids |
| 04/11/2000 | US6048523 Polyester cyclic compounds, their complexes and bonded bodies |
| 04/08/2000 | CA2285120A1 Heterocycles |
| 04/06/2000 | WO2000018801A2 Ncam binding compounds |
| 04/06/2000 | WO2000018795A2 Compositions and methods for wt1 specific immunotherapy |
| 04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/06/2000 | WO2000018429A2 Vaccine based on attenuated $i(haemophilus somnus) |
| 04/06/2000 | WO2000018424A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 04/06/2000 | WO2000018423A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO1999064596A3 Proteins regulating gene expression |
| 04/06/2000 | WO1999061626A3 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
| 04/06/2000 | WO1999059525A9 Broad spectrum microbicidal and spermicidal compositions, devices, and methods |
| 04/06/2000 | DE19845314A1 Agent for treatment of erectile dysfunction with broader effect than sildenafil, containing procyanidin compound and optionally L-arginine |
| 04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | CA2343975A1 Ncam binding compounds |
| 04/06/2000 | CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/05/2000 | EP0989973A1 Chalcones having antiproliferative activity |
| 04/05/2000 | EP0989972A1 Prostaglandin pharmaceutical compositions |
| 04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
| 04/04/2000 | US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| 04/04/2000 | US6046329 Uracil derivatives |
| 04/04/2000 | US6046244 Composition comprising prostaglandin e1, skin penetration enhancer, polysaccharide gum, lipophilic compound, acidic buffer system |
| 04/04/2000 | US6046240 Methods for treating female sexual dysfunction |
| 04/04/2000 | US6046222 Preventing or delaying the noninsulin dependent diabetes mellitus comprising administering to a host suffering from polycystic ovary syndrom or suffered from gestational diabetes a therapeutically effective amount of pioglitazone |
| 04/04/2000 | US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 04/04/2000 | US6046183 Synergistic mixture of finasteride and doxazosin |
| 04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
| 04/04/2000 | US6045501 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017361A2 Interferon-epsilon |
| 03/30/2000 | WO2000017348A1 G protein-coupled receptor agonists or antagonists |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | WO2000016805A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 03/30/2000 | WO2000016789A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations |
| 03/30/2000 | WO2000016764A2 Pharmaceutical compositions comprising derivatives of sulphur acids |
| 03/30/2000 | WO2000016632A2 Environmentally benign crop protection agents |
| 03/30/2000 | WO2000016624A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof |
| 03/30/2000 | WO2000016623A1 Antifouling agents |
| 03/30/2000 | WO1999063931A9 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor |
| 03/30/2000 | WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 03/30/2000 | DE19849107A1 Verfahren zur Entfernung von unerwünschten, toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A process for the removal of undesired toxic alkaloids from plants or from plant preparations |
| 03/30/2000 | CA2689373A1 G protein-coupled receptor antagonists |
| 03/30/2000 | CA2345233A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof |
| 03/30/2000 | CA2345232A1 Environmentally benign crop protection agents |
| 03/30/2000 | CA2345111A1 Antifouling agents |
| 03/30/2000 | CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | CA2343918A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 03/30/2000 | CA2342773A1 Interferon-epsilon |
| 03/29/2000 | EP0988860A1 NKT CELL ACTIVATORS CONTAINING $g(a)-GLYCOSYLCERAMIDES |
| 03/29/2000 | EP0988377A1 Zinc finger protein derivatives and methods therefor |
| 03/29/2000 | EP0988374A1 Hydrophilic composition containing protease produced by vibrio |
| 03/29/2000 | EP0988312A1 17$g(b)-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS |
| 03/29/2000 | EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 03/29/2000 | EP0988295A1 Heterocyclic substituted piperidines and uses thereof |
| 03/29/2000 | EP0988048A1 Ligand/lytic peptide compositions and methods of use |
| 03/29/2000 | EP0988009A1 Device and method for treatment of dysmenorrhea |
| 03/29/2000 | EP0987943A1 A novel method of detecting and treating cancer |
| 03/29/2000 | EP0801554A4 Formulations and methods for reducing skin irritation |
| 03/29/2000 | EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses |
| 03/29/2000 | CN1248915A Medicament against infertility and for increasing fertility |
| 03/29/2000 | CN1248465A Method for producing Anruneixiao medicinal liquid |
| 03/29/2000 | CN1248448A Scorption and ant health care liquor |
| 03/29/2000 | CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use |
| 03/28/2000 | US6043358 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 03/28/2000 | US6043250 Treating or preventing inflammatory diseases |
| 03/28/2000 | US6043235 11β-aryl-17, 17-spirothiolane-substituted steroids |
| 03/28/2000 | US6043234 Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen |
| 03/23/2000 | WO2000015788A2 Dna sequence encoding oncofetal ferritin protein |
| 03/23/2000 | WO2000015770A2 Human serine/threonine protein kinases |
| 03/23/2000 | WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 03/23/2000 | WO2000015253A1 Human chorionic gonadotropin vaccines |
| 03/23/2000 | WO2000015245A2 Stable liquid formulations of botulinum toxin |
| 03/23/2000 | WO2000015233A1 Compositions for the treatment of male erectile dysfunction |
| 03/23/2000 | WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 03/23/2000 | WO2000015222A1 FUSED PYRIDINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/23/2000 | WO1999066901A3 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | CA2343578A1 Human serine/threonine protein kinases |